semaglutide and alzheimer's Blockbuster GLP-1 Diabetes Weight Loss Drugs Fails in Trial Obesity drug semaglutide fails to

Compounded semaglutide is a custom-made version of the weight loss drugs approved by the Food and Drug Administration (FDA)

In order to achieve the purpose, the technical scheme of the invention is as follows: the high-stability reduced glutathione for injection is characterized in that: when the amount of the reduced glutathione is 0.6g, the formula components are as follows: reduced glutathione 0.6g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 2g When the amount of the reduced glutathione for injection is 1.0g, the formula components are as follows: reduced glutathione 1.0g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 3.3g When the reduced glutathione for injection is 1.5g, the formula components are as follows: reduced glutathione 1.5g Adjusting the pH of the solution to 6.0-7.0 with 10% sodium hydroxide solution Adding water for injection to 5.0g Wherein, in the liquid preparation process, nitrogen is continuously filled in the liquid preparation and filling processes to keep the oxygen content in the solution below 1.5 ppm

Higher concentration formulations sometimes demonstrate different stability profiles than more dilute preparations, though this relationship is not always linear or predictable

Am J Physiol1964 Nov;207:1146-54

The most common side effect is simply pain at the injection site